Drs Michael Morton and Richard Knight thoroughly enjoyed the Bionow 2018 Awards Dinner at the Mere Golf Resort & Spa, Cheshire on 29th November.
The awards which recognise excellence, outstanding achievement and enterprise in a sector that is worth more than £13bn to the North’s economy, were sponsored by Manchester Science Partnerships, Alderley Park, Appleyard Lees, DLA Piper and World Courier.
ApconiX, who won last year’s Start-Up of The Year Award, were thrilled to see Alderley Park companies among the winners again this year.
Blueberry Therapeutics won the Company of The Year Award. Blueberry has exclusive worldwide access to a nanodelivery platform, which significantly enhances delivery of drugs into cells and tissues. This is used to create safe, effective “nanomedicines” to treat several serious unmet medical needs. Blueberry has had a remarkable year, including its BB2603 Phase I/II trial successfully meeting its primary endpoint in patients with both onychomycosis (fungal nail infection) and concomitant tinea pedis (athletes foot), as well as completing its £10m series B Fundraising.
Seda Pharmaceutical Development Services won the Technical Service Award. Seda enable the rapid and efficient development of optimal medicinal products. The company provides coherent and synergistic support across the four key disciplines of Chemistry Manufacturing and Controls (CMC), Drug Delivery System Scouting, Clinical Pharmacology and Biopharmaceutics and Biotech Investment Support.
“Having worked with both companies and watched them grow from strength to strength over recent years, we couldn’t be more delighted to see their hard work and success recognised,” commented Mike.